These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20845996)

  • 1. Survivin: a promising biomarker in breast carcinoma.
    Adamkov M; Halasova E; Kajo K; Machalekova K; Vybohova D; Varga I; Rajcany J
    Neoplasma; 2010; 57(6):572-7. PubMed ID: 20845996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of anti-apoptotic protein survivin in dysplastic nevi.
    Adamkov M; Lauko L; Balentova S; Pec J; Pec M; Rajcani J
    Neoplasma; 2009; 56(2):130-5. PubMed ID: 19239327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin in breast lesions: immunohistochemical analysis of 196 cases.
    Adamkov M; Drahošová S; Chylíková J; Výbohová D
    Pol J Pathol; 2017; 68(4):297-305. PubMed ID: 29517199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma.
    Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J
    Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear survivin as a biomarker for non-small-cell lung cancer.
    Lu B; Gonzalez A; Massion PP; Shyr Y; Shaktour B; Carbone DP; Hallahan DE
    Br J Cancer; 2004 Aug; 91(3):537-40. PubMed ID: 15266313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of survivin in breast cancer.
    Kennedy SM; O'Driscoll L; Purcell R; Fitz-Simons N; McDermott EW; Hill AD; O'Higgins NJ; Parkinson M; Linehan R; Clynes M
    Br J Cancer; 2003 Apr; 88(7):1077-83. PubMed ID: 12671708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.
    Yin W; Chen N; Zhang Y; Zeng H; Chen X; He Y; Wang X; Zhou Q
    Mod Pathol; 2006 Nov; 19(11):1487-97. PubMed ID: 16892011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of survivin expression in a spectrum of benign to malignant lesions of the breast.
    Singh M; Bleile MJ; Shroyer AL; Heinz D; Jarboe EA; Shroyer KR
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):296-304. PubMed ID: 15536328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma.
    Shintani M; Sangawa A; Yamao N; Kamoshida S
    Int J Clin Exp Pathol; 2013; 6(12):2919-27. PubMed ID: 24294379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.
    Engels K; Knauer SK; Metzler D; Simf C; Struschka O; Bier C; Mann W; Kovács AF; Stauber RH
    J Pathol; 2007 Apr; 211(5):532-540. PubMed ID: 17334981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of survivin and clinical correlation in patients with breast cancer.
    Sohn DM; Kim SY; Baek MJ; Lim CW; Lee MH; Cho MS; Kim TY
    Biomed Pharmacother; 2006 Jul; 60(6):289-92. PubMed ID: 16876381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis.
    Nassar A; Sexton D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):221-6. PubMed ID: 18301249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression in breast lobular carcinoma: correlations with normal breast tissue and clinicomorphological parameters.
    Adamkov M; Výbohová D; Horáček J; Kovalská M; Furjelová M
    Acta Histochem; 2013 Jun; 115(5):412-7. PubMed ID: 23219440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer.
    Vischioni B; van der Valk P; Span SW; Kruyt FA; Rodriguez JA; Giaccone G
    Ann Oncol; 2004 Nov; 15(11):1654-60. PubMed ID: 15520067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase IX: a promising diagnostic and prognostic biomarker in breast carcinoma.
    Furjelová M; Kovalská M; Jurková K; Horáček J; Carbolová T; Adamkov M
    Acta Histochem; 2014 Jan; 116(1):89-93. PubMed ID: 23816158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of survivin in serous tumors of the ovary.
    Tringler B; Lehner R; Shroyer AL; Shroyer KR
    Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):40-3. PubMed ID: 15163018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular localization of survivin determines biological behavior in colorectal cancer.
    Qi G; Tuncel H; Aoki E; Tanaka S; Oka S; Kaneko I; Okamoto M; Tatsuka M; Nakai S; Shimamoto F
    Oncol Rep; 2009 Sep; 22(3):557-62. PubMed ID: 19639203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
    Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
    Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular localisation of survivin: impact on the prognosis in colorectal cancer.
    Ponnelle T; Chapusot C; Martin L; Bouvier AM; Plenchette S; Faivre J; Solary E; Piard F
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):504-10. PubMed ID: 15902487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.